An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

NCT00109057 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Avastin (bevacizumab)

Sponsor

Genentech, Inc.